Navigation Links
Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Date:10/26/2008

safety profile and promising clinical outcomes comparable to other antibiotics either on the market or in development. What is most encouraging about PTK 0796 is that it is the first broad-spectrum antibiotic with activity against MRSA that will have the oral and IV formulations needed for seamless transition of treatment from the hospital out into the community. I look forward to continued progress of this program."

PTK 0796 represents a new class of antibiotics that has shown potent, broad-spectrum activity against multi-drug resistant and susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), as well as Gram-negative, anaerobic and atypical bacteria. Paratek is developing PTK 0796 as a firstline agent for empiric therapy for the leading infections requiring hospitalization, such as cSSSIs and moderate to severe community-acquired pneumonia (CAP).

Thomas J. Bigger, Paratek's President and CEO, stated, "PTK 0796 is the only once-a-day, oral and IV MRSA-active compound in development with a spectrum broad enough for single agent treatment of cSSSI and CAP. These attributes have generated great enthusiasm and interest among investigators planning to participate in our Phase 3 program. We expect to initiate our pivotal Phase 3 trials in the U.S. and overseas for the treatment of cSSSI patients, including those with diabetic foot infections, in the first quarter of 2009. We are thrilled by the rapid advancement of these efforts and by the ability to present our Phase 2 results at the leading infectious diseases conference."

Background on Aminomethylcyclines (AMCs)

Using Paratek's novel medicinal chemistry techniques, AMCs were evolved from tetracycline antibiotics as potential agents to combat multiple antibiotic-resistant bacteria, including MRSA, penicillin-resistant Streptococcus pneumoniae (PRSP), vancomycin-resistant Enterococcus (VRE), multidrug resistant Escherichia coli and other difficult-t
'/>"/>

SOURCE Paratek Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
2. Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections
3. Paratek to Present Clinical Data in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Spherix Reports Second Quarter Earnings
6. Tapestry Reports Second Quarter 2007 Results
7. Callisto Reports on Second-Quarter 2007 Milestones
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
10. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
11. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... WAYNE, N.J. , Dec. 19, 2014  In the Friday, ... , a 16-page supplement dedicated to Healthcare Information Technology (HIT) features ... innovation in Healthcare IT in partnership with several leading healthcare organizations. ... be distributed across several major metropolitan markets, such as ... Washington DC / Baltimore , Minneapolis ...
(Date:12/19/2014)... , December 19, 2014 TODAY, ... in the World announced the appointment of Peter ... Vonsée, as Chief Channels and Partner Officer. ... 2004 through to its acquisition by Oracle in 2011. ... at Geneva and subsequently Convergys, ...
(Date:12/19/2014)... Dec. 19, 2014  Newport Corporation (NASDAQ: ... Ph.D. has joined the company,s Board of Directors.  ... and a director of Evans Analytical Group, a ... and analytical services to companies in a wide ... joining Evans Analytical Group, Dr. Kadia spent nine ...
Breaking Medicine Technology:USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT 2Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4Siddhartha Kadia, Ph.D. Joins Board of Directors of Newport Corporation 2
... Columbia, Jan. 7, 2011 Enox Biopharma, Inc. CEO, John ... Emerging Company Finance Conference on Wednesday, January 12 at 8:10 ... Francis Drake Hotel in San Francisco. Dr. ... ability to embed nitric oxide into polymer based medical devices ...
... ANGELES, Jan. 7, 2011 MD+DI ( ... ( Medical Product Manufacturing News ), and OrthoTec, ... today announced session topics for the upcoming virtual event, ... 26, 2011, from 11am until 5pm Eastern time. ...
Cached Medicine Technology:Enox Biopharma, Inc. to Present at OneMedForum Emerging Company Finance Conference. 2Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices Offers Sessions on Orthopedic and Cardio Applications 2Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices Offers Sessions on Orthopedic and Cardio Applications 3
(Date:12/19/2014)... All children should have their eyesight checked between the ... experts say. The new vision-screening guidelines for preschool-aged ... National Center for Children,s Vision Health. The panel ... for eye problems, particularly vision issues that require ... strabismus (a disorder of eye alignment). Early detection ...
(Date:12/19/2014)... Dense bunches of bacteria called biofilms can be found on ... The researchers said these biofilms were especially prevalent on ... these biofilms may represent an increased likelihood of colon cancer ... risk for the disease, the researchers said. Like tooth ... the mucus layer of cells lining the colon, according to ...
(Date:12/19/2014)... NC (PRWEB) December 19, 2014 Surviving Mesothelioma ... and EPA information indicates that these pipes can leach asbestos ... go to the full story on the Surviving Mesothelioma ... the erosion of natural asbestos deposits, decaying water mains made ... drinking water. , To protect consumers from mesothelioma ...
(Date:12/19/2014)... Kan. (PRWEB) December 19, 2014 B. ... exclusively to healthcare providers, has been retained to lead ... Estes Park Medical Center in Estes Park, Colo. The ... E. Smith has recently placed more than 900 healthcare ... (EPMC) is a 25-bed, not-for-profit critical access hospital and ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 Novellus ... Patient Care: Pharmacy & Clinics™, an independent journal ... team treating and caring for patients inside the ... care expands to provide optimal access to quality ... a forum for the team treating and coordinating ...
Breaking Medicine News(10 mins):Health News:Preschoolers Need Eye Screening, Experts Say 2Health News:Could Bacteria Play a Role in Colon Cancer? 2Health News:Surviving Mesothelioma Warns of Potential Mesothelioma Risk from Cement Water Pipes 2Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 3Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 2Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 3
... to Accelerate Patient Access to Pixantrone through ProgramSEATTLE, May ... CTIC) today announced that pixantrone is now available on ... by IDIS to healthcare professionals for the treatment of ... either relapsed after standard therapies or is refractory to ...
... Dental convention examines mass disaster managementANAHEIM, Calif., May 4 , WHEN: ... Anaheim Convention Center (ACC), ... Anaheim, CA 92802, CONTACTS: Jessica Joisten 916.524.7686 and Doug Elmets 916.206.8662, ... attend CDA Presents The Art ...
... MD, a pioneering researcher in the field of Obsessive-Compulsive Disorder (OCD), has ... July 1, 2009. , ... New York, NY (Vocus) May 4, 2009 ... Obsessive-Compulsive Disorder (OCD), has been named Chair of Psychiatry at Mount ...
... HOLLYWOOD, Calif., May 4 IPC The Hospitalist Company, Inc. (Nasdaq: ... for the first quarter ended March 31, 2009.First Quarter 2009 Highlights (comparisons are ... Net revenue increased 26% to $76.1 million, with same-market area net ... , , Patient ...
... Haemonetics Corporation (NYSE: HAE ) today reported ... consecutive quarter of double digit revenue growth. For the ... 16%; operating income of $86 million, up 22%; net income ... $2.27, up 17%. The Company also announced fiscal 2010 ...
... ManagementContinued Progress on Debt ReductionBIRMINGHAM, Ala., May 4 ... its results of operations for the first quarter ended ... revenues of $475.1 million for the first quarter of ... of 2008, or an increase of 2.3%. This increase ...
Cached Medicine News:Health News:Pixantrone Now Available in Europe on a Named-Patient Basis 2Health News:Pixantrone Now Available in Europe on a Named-Patient Basis 3Health News:Pixantrone Now Available in Europe on a Named-Patient Basis 4Health News:Dentistry and Mass Disasters: A Dentist's Role as a First Responder During a Public Health Emergency 2Health News:Dentistry and Mass Disasters: A Dentist's Role as a First Responder During a Public Health Emergency 3Health News:Wayne K. Goodman, MD, Renowned Expert on Obsessive Compulsive Disorder, Joins Mount Sinai as Chair of Psychiatry 2Health News:Wayne K. Goodman, MD, Renowned Expert on Obsessive Compulsive Disorder, Joins Mount Sinai as Chair of Psychiatry 3Health News:IPC The Hospitalist Company Reports Record First Quarter 2009 Results 2Health News:IPC The Hospitalist Company Reports Record First Quarter 2009 Results 3Health News:IPC The Hospitalist Company Reports Record First Quarter 2009 Results 4Health News:IPC The Hospitalist Company Reports Record First Quarter 2009 Results 5Health News:IPC The Hospitalist Company Reports Record First Quarter 2009 Results 6Health News:IPC The Hospitalist Company Reports Record First Quarter 2009 Results 7Health News:IPC The Hospitalist Company Reports Record First Quarter 2009 Results 8Health News:IPC The Hospitalist Company Reports Record First Quarter 2009 Results 9Health News:IPC The Hospitalist Company Reports Record First Quarter 2009 Results 10Health News:IPC The Hospitalist Company Reports Record First Quarter 2009 Results 11Health News:IPC The Hospitalist Company Reports Record First Quarter 2009 Results 12Health News:Haemonetics Shares Success of Outstanding Fiscal 2009 Performance with Employees 2Health News:HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009 2Health News:HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009 3Health News:HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009 4Health News:HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009 5Health News:HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009 6Health News:HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009 7Health News:HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009 8Health News:HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009 9Health News:HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009 10Health News:HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009 11Health News:HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009 12Health News:HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009 13Health News:HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009 14Health News:HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009 15Health News:HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009 16Health News:HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009 17
37°C incubator for DianaGel cards....
Bio-Rad's ScanGel® cards for blood typing provide standardized protocols for all the cards: same incubation time (if required), same centrifugation time and speed....
... different sized High-Throughput Submarine Systems are ... samples from microtitre plates. Analyze high ... synthetic oligos or PCR products simultaneously. ... for accuracy and speed with additional ...
... The ID-Micro Typing System™ ... for a broad range of ... include antibody screening and identification, ... phenotyping, compatibility testing, reverse serum ...
Medicine Products: